Therapeutic Solutions International Inc
Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases in the United States. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, and traumatic brain injury, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulfora… Read more
Therapeutic Solutions International Inc (TSOI) - Total Assets
Latest total assets as of September 2024: $3.60 Million USD
Based on the latest financial reports, Therapeutic Solutions International Inc (TSOI) holds total assets worth $3.60 Million USD as of September 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Therapeutic Solutions International Inc - Total Assets Trend (2007–2023)
This chart illustrates how Therapeutic Solutions International Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Therapeutic Solutions International Inc - Asset Composition Analysis
Current Asset Composition (December 2023)
Therapeutic Solutions International Inc's total assets of $3.60 Million consist of 2.6% current assets and 97.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0.9% |
| Accounts Receivable | $19.20K | 0.6% |
| Inventory | $22.57K | 0.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $2.70 Million | 82.1% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2007–2023)
This chart illustrates how Therapeutic Solutions International Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Therapeutic Solutions International Inc's current assets represent 2.6% of total assets in 2023, a decrease from 100.0% in 2007.
- Cash Position: Cash and equivalents constituted 0.9% of total assets in 2023, down from 100.0% in 2007.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 82.0% of total assets, an increase from 0.0% in 2007.
- Asset Diversification: The largest asset category is intangible assets at 82.1% of total assets.
Therapeutic Solutions International Inc Competitors by Total Assets
Key competitors of Therapeutic Solutions International Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Halozyme Therapeutics Inc
NASDAQ:HALO
|
USA | $2.22 Billion |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $7.59 Billion |
|
ESSA Pharma Inc
NASDAQ:EPIX
|
USA | $110.50 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
Therapeutic Solutions International Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Therapeutic Solutions International Inc generates 0.03x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Therapeutic Solutions International Inc is currently not profitable relative to its asset base.
Therapeutic Solutions International Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.27 | 0.09 | 0.06 |
| Quick Ratio | 0.26 | 0.08 | 0.06 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-1.34 Million | $ -1.87 Million | $ -2.21 Million |
Therapeutic Solutions International Inc - Advanced Valuation Insights
This section examines the relationship between Therapeutic Solutions International Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.41 |
| Latest Market Cap to Assets Ratio | 0.16 |
| Asset Growth Rate (YoY) | -8.7% |
| Total Assets | $3.29 Million |
| Market Capitalization | $512.27K USD |
Valuation Analysis
Below Book Valuation: The market values Therapeutic Solutions International Inc's assets below their book value (0.16 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Therapeutic Solutions International Inc's assets decreased by 8.7% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Therapeutic Solutions International Inc (2007–2023)
The table below shows the annual total assets of Therapeutic Solutions International Inc from 2007 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | $3.29 Million | -8.70% |
| 2022-12-31 | $3.61 Million | +110.14% |
| 2021-12-31 | $1.72 Million | +184.32% |
| 2020-12-31 | $603.47K | +94.04% |
| 2019-12-31 | $311.00K | +50.29% |
| 2018-12-31 | $206.93K | +680.14% |
| 2017-12-31 | $26.52K | -74.71% |
| 2016-12-31 | $104.88K | -47.88% |
| 2015-12-31 | $201.22K | 0.00% |
| 2014-12-31 | $201.22K | -4.57% |
| 2013-12-31 | $210.84K | +4.61% |
| 2012-12-31 | $201.56K | -94.17% |
| 2011-12-31 | $3.46 Million | +345861500.00% |
| 2010-12-31 | $1.00 | -100.00% |
| 2009-12-31 | $313.15K | +2333.00% |
| 2008-12-31 | $12.87K | -76.08% |
| 2007-12-31 | $53.80K | -- |